Black Diamond Therapeutics (BDTX) EPS (Weighted Average and Diluted) (2020 - 2021)
Historic EPS (Weighted Average and Diluted) for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q4 2021 value amounting to -$0.71.
- Black Diamond Therapeutics' EPS (Weighted Average and Diluted) fell 1269.84% to -$0.71 in Q4 2021 from the same period last year, while for Dec 2021 it was -$3.26, marking a year-over-year decrease of 6186.91%. This contributed to the annual value of -$3.47 for FY2021, which is 6926.83% down from last year.
- According to the latest figures from Q4 2021, Black Diamond Therapeutics' EPS (Weighted Average and Diluted) is -$0.71, which was down 1269.84% from -$0.95 recorded in Q3 2021.
- Over the past 5 years, Black Diamond Therapeutics' EPS (Weighted Average and Diluted) peaked at -$0.41 during Q2 2020, and registered a low of -$0.95 during Q3 2021.